Jaap Van Der Louw

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Akzo Nobel N.v., N.v. Organon, Pharmacopeia Drug Discovery, Inc.. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaap Van Der Louw. Retrieved from https://idiyas.com/inventor/jaap-van-der-louw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 41.2

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 1

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 32(Granted Patents)

Location History:

Pauwoog, NL (2001)
EN Oss, NL (2004 - 2005)
Bh Oss, NL (2005)
Oss, NL (1998 - 2012)

Company Filing History:

Pharmacopeia Drug Discovery, Inc.

patents

Years Active: 1998-2012

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8124647 - Non-steroidal androgens compounds (2012-02-28),

2. 7812036 - Androgens (2010-10-12),

3. 7795280 - Indoles useful in the treatment of androgen-receptor related diseases (2010-09-14),

4. 7582622 - Steroids having a mixed androgenic and progestagenic profile (2009-09-01),

5. 7037916 - Pyrimidine derivatives as IL-8 receptor antagonists (2006-05-02),

6. 6949531 - 14 β, 16, 17-methylene steroids as novel androgens (2005-09-27),

7. 6881728 - 14-β, 17-α-hydroxymethylandrostane derivatives as androgens (2005-04-19),

8. 6780854 - Orally active androgens (2004-08-24),

9. 6756366 - Orally active androgens (2004-06-29),

10. 6706700 - 14&bgr;,15&bgr;-methylene-17&agr;-hydroxymethyl-androgens (2004-03-16),

11. 6552011 - (Androst-5-en-17beta -yl)alkyl sulfoxides and sulfones and their use for control of fertility (2003-04-22),

12. 6541465 - Orally active androgens (2003-04-01),

13. 6313108 - Orally active androgens (2001-11-06),

14. 6262282 - 17&bgr;-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis (2001-07-17),

15. 6251887 - 17&bgr;-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives (2001-06-26),

Title: Jaap Van Der Louw: Innovator in Non-Steroidal Androgens

Introduction

Jaap Van Der Louw is a prominent inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal androgen compounds. With a total of 17 patents to his name, his work has had a substantial impact on androgen-receptor related treatments.

Latest Patents

Among his latest patents, Van Der Louw has developed non-steroidal compounds that exhibit affinity for the androgen receptor. This invention provides innovative solutions for androgen-receptor related treatments, featuring a structure according to a specific formula or its salt or hydrate forms. Additionally, he has worked on compounds characterized by a defined structure, which also includes salt or hydrate forms, further advancing the understanding and application of androgens in medical treatments.

Career Highlights

Throughout his career, Jaap Van Der Louw has been associated with notable companies such as Akzo Nobel N.V. and N.V. Organon. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Dirk Leysen and Hubert Jan Jozef Loozen. Their collaborative efforts have played a crucial role in the advancement of the projects they have undertaken together.

Conclusion

Jaap Van Der Louw's innovative work in the field of non-steroidal androgens has established him as a key figure in pharmaceutical research. His contributions continue to influence the development of effective treatments for androgen-receptor related conditions.

Profile summary based on public USPTO records.